| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | crizotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.031 | 0.4 |
| mRNA | 1S,3R-RSL-3 | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | 0.029 | 0.4 |
| mRNA | BIX-01294 | CTRPv2 | pan-cancer | AAC | 0.031 | 0.4 |
| mRNA | ifosfamide | CTRPv2 | pan-cancer | AAC | -0.049 | 0.4 |
| mRNA | SU11274 | CTRPv2 | pan-cancer | AAC | 0.031 | 0.4 |
| mRNA | BCL-LZH-4 | CTRPv2 | pan-cancer | AAC | -0.046 | 0.4 |
| mRNA | AZD-7545 | CTRPv2 | pan-cancer | AAC | 0.033 | 0.4 |
| mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | -0.037 | 0.4 |
| mRNA | MG-132 | CTRPv2 | pan-cancer | AAC | 0.053 | 0.4 |